# EDGAR Filing Document

**Accession Number:** 0001419554
**File Stem:** 0001641172-25-016304
**Filing Date:** 2025-6
**Character Count:** 2450
**Document Hash:** 8af49b0eefcbcf8f04c1005a264cf5b1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-016304.hdr.sgml**: 20250729

**ACCESSION NUMBER**: 0001641172-25-016304

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250624

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bone Biologics Corp
- **CENTRAL INDEX KEY:** 0001419554
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 421743430
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2 BURLINGTON WOODS DRIVE,
- **STREET 2:** SUITE 100,
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** (781) 552-4452

**MAIL ADDRESS:**
- **STREET 1:** 2 BURLINGTON WOODS DRIVE,
- **STREET 2:** SUITE 100,
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bone Biologics, Corp.
- **DATE OF NAME CHANGE:** 20140924

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AFH ACQUISITION X, INC.
- **DATE OF NAME CHANGE:** 20071127

**Bone Biologics Corporation**

**2 Burlington Woods Drive, Suite 100**

**Burlington, MA 01803**

June 24, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Jane Park

---

| | |
|:---|:---|
| Re: | **Bone Biologics Corporation** <br> **Registration Statement on Form S-1**<br> **File No. 333-288282** |

---

Ladies and Gentlemen:

In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Bone Biologics Corporation, a Delaware corporation, hereby requests that the effectiveness of the registration statement on Form S-1 (File No. 333-288282), initially filed with the U.S. Securities and Exchange Commission on June 24, 2025, be accelerated so that the registration statement becomes effective at 4:30 p.m. Eastern Time on June 26, 2025 or as soon thereafter as practicable.

If you have any questions regarding this request, please contact Alexander R. McClean of Harter Secrest & Emery at (585) 231-1248.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Bone Biologics Corporation | Bone Biologics Corporation |
| By: | */s/ Jeffrey Frelick* |
|  | Jeffrey Frelick |
|  | President and Chief Executive Officer |

---